Impact of immunotherapy in populations underrepresented in clinical trials is demonstrated by real-world data.

Published Date: 13 Dec 2023

First-line immunotherapy for advanced non-small cell lung cancer (NSCLC) produced comparable outcomes, according to new research published in the December 2023 issue of the Journal of the National Comprehensive Cancer Network.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Biomarker-Selected Treatment Shows Promise for Bladder Preservation in MIBC

2.

FDA Investigating Blood Cancer Risk With Gene Therapy Skysona

3.

Surviving cancer, still suffering: Survey reveals gaps in follow‑up care

4.

Charles III, King of Kings, is Cancerous.

5.

The Truth About Apple AirPods


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot